Sustainable treatment of glaucoma patients with cardiovascular diseases
As life expectancy increases, the incidence of glaucoma is expected to rise worldwide. The review presents data on the comorbidity and polypharmacy of old and senile patients with glaucoma. Such patients also often have polypathia: on average, they have 6.3±0.6 concomitant somatic diseases. Appro...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2020-09-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/495 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849394807524294656 |
|---|---|
| author | L. V. Yakubova S. M. Kosakyan L. V. Vasilenkova |
| author_facet | L. V. Yakubova S. M. Kosakyan L. V. Vasilenkova |
| author_sort | L. V. Yakubova |
| collection | DOAJ |
| description | As life expectancy increases, the incidence of glaucoma is expected to rise worldwide. The review presents data on the comorbidity and polypharmacy of old and senile patients with glaucoma. Such patients also often have polypathia: on average, they have 6.3±0.6 concomitant somatic diseases. Approximately one in five glaucoma patients receives both a systemic and local beta-blocker (ВВ). Parallel use of local and systemic drugs in glaucoma patients is likely to cause drug interaction, increase side effects and contribute to an earlier onset of the tachyphylaxis. The selectivity of oral and local ВВ is one of the factors contributing to the prediction of their additive effect. The data on the expediency of prescribing brimonidine as the first-choice drug for glaucoma and hypertension patients who were previously prescribed systemic ВВ are presented. |
| format | Article |
| id | doaj-art-535c96c52a8d47bfae1d9d9872217eb0 |
| institution | Kabale University |
| issn | 2072-0076 2587-5760 |
| language | Russian |
| publishDate | 2020-09-01 |
| publisher | Real Time Ltd |
| record_format | Article |
| series | Российский офтальмологический журнал |
| spelling | doaj-art-535c96c52a8d47bfae1d9d9872217eb02025-08-20T03:39:53ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602020-09-0113310310710.21516/2072-0076-2020-13-3-103-107308Sustainable treatment of glaucoma patients with cardiovascular diseasesL. V. Yakubova0S. M. Kosakyan1L. V. Vasilenkova2Helmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesHelmholtz National Medical Research Center of Eye DiseasesAs life expectancy increases, the incidence of glaucoma is expected to rise worldwide. The review presents data on the comorbidity and polypharmacy of old and senile patients with glaucoma. Such patients also often have polypathia: on average, they have 6.3±0.6 concomitant somatic diseases. Approximately one in five glaucoma patients receives both a systemic and local beta-blocker (ВВ). Parallel use of local and systemic drugs in glaucoma patients is likely to cause drug interaction, increase side effects and contribute to an earlier onset of the tachyphylaxis. The selectivity of oral and local ВВ is one of the factors contributing to the prediction of their additive effect. The data on the expediency of prescribing brimonidine as the first-choice drug for glaucoma and hypertension patients who were previously prescribed systemic ВВ are presented.https://roj.igb.ru/jour/article/view/495beta-blockerscomorbiditypolypathiapolypragmasiacardiovascular pathologyglaucoma |
| spellingShingle | L. V. Yakubova S. M. Kosakyan L. V. Vasilenkova Sustainable treatment of glaucoma patients with cardiovascular diseases Российский офтальмологический журнал beta-blockers comorbidity polypathia polypragmasia cardiovascular pathology glaucoma |
| title | Sustainable treatment of glaucoma patients with cardiovascular diseases |
| title_full | Sustainable treatment of glaucoma patients with cardiovascular diseases |
| title_fullStr | Sustainable treatment of glaucoma patients with cardiovascular diseases |
| title_full_unstemmed | Sustainable treatment of glaucoma patients with cardiovascular diseases |
| title_short | Sustainable treatment of glaucoma patients with cardiovascular diseases |
| title_sort | sustainable treatment of glaucoma patients with cardiovascular diseases |
| topic | beta-blockers comorbidity polypathia polypragmasia cardiovascular pathology glaucoma |
| url | https://roj.igb.ru/jour/article/view/495 |
| work_keys_str_mv | AT lvyakubova sustainabletreatmentofglaucomapatientswithcardiovasculardiseases AT smkosakyan sustainabletreatmentofglaucomapatientswithcardiovasculardiseases AT lvvasilenkova sustainabletreatmentofglaucomapatientswithcardiovasculardiseases |